• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本某地区队列中肥厚型心肌病的心脏性猝死相关事件——高知县龙马研究结果

Sudden Cardiac Death-Relevant Events of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From the Kochi RYOMA Study.

作者信息

Kubo Toru, Baba Yuichi, Ochi Yuri, Takahashi Asa, Hirota Takayoshi, Yamasaki Naohito, Hamashige Naohisa, Yamamoto Katsuhito, Kondo Fumiaki, Bando Kanji, Yamada Eisuke, Furuno Takashi, Yabe Toshikazu, Doi Yoshinori L, Kitaoka Hiroaki

机构信息

Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University Nankoku Japan.

Department of Cardiology, Chikamori Hospital Kochi Japan.

出版信息

Circ Rep. 2020 Jul 2;2(8):433-439. doi: 10.1253/circrep.CR-20-0056.

DOI:10.1253/circrep.CR-20-0056
PMID:33693265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7819656/
Abstract

Sudden cardiac death (SCD) is a most devastating complication of hypertrophic cardiomyopathy (HCM). The aim of this study was to clarify the clinical features of HCM in patients who experienced SCD-relevant events in an aged Japanese community. In 2004, we established a cardiomyopathy registration network in Kochi Prefecture, and herein report on 293 patients with HCM who are followed as part of the registry. The mean (±SD) age at registration and diagnosis was 63±14 and 56±16 years, respectively. SCD-relevant events occurred in 19 patients during a mean follow-up period of 6.1±3.2 years (incidence rate 1.0%/year): sudden death in 9 patients, successful recovery from cardiopulmonary arrest in 4 patients, and appropriate implantable cardioverter-defibrillator discharge in 6 patients. At registration, 13 patients were in the dilated phase of HCM (D-HCM). During the follow-up period, HCM developed to D-HCM in 21 patients; thus, 34 patients in total had D-HCM. Multivariate analysis revealed that D-HCM at registration or during follow-up and detection of non-sustained ventricular tachycardia (NSVT) during follow-up were significant predictors of SCD-relevant events. In this HCM population in an aged Japanese community, the annual rate of SCD-relevant events was 1.0%. HCM developed to D-HCM in a considerable number of patients, and D-HCM and NSVT were shown to be independently associated with an increased risk of SCD-relevant events.

摘要

心脏性猝死(SCD)是肥厚型心肌病(HCM)最具毁灭性的并发症。本研究的目的是阐明在日本老年社区中经历过与SCD相关事件的HCM患者的临床特征。2004年,我们在高知县建立了心肌病登记网络,本文报告了作为该登记系统一部分进行随访的293例HCM患者。登记和诊断时的平均(±标准差)年龄分别为63±14岁和56±16岁。在平均6.1±3.2年的随访期内,19例患者发生了与SCD相关的事件(发病率为1.0%/年):9例患者猝死,4例患者心肺复苏成功,6例患者植入式心律转复除颤器适当放电。登记时,13例患者处于HCM的扩张期(D-HCM)。在随访期间,21例患者的HCM发展为D-HCM;因此,共有34例患者患有D-HCM。多变量分析显示,登记时或随访期间的D-HCM以及随访期间检测到非持续性室性心动过速(NSVT)是与SCD相关事件的重要预测因素。在这个日本老年社区的HCM人群中,与SCD相关事件的年发生率为1.0%。相当数量的患者HCM发展为D-HCM,并且D-HCM和NSVT被证明与SCD相关事件风险增加独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b03/7819656/59f0deaa6e70/circrep-2-433-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b03/7819656/a4ff324efd28/circrep-2-433-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b03/7819656/546cb76ef595/circrep-2-433-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b03/7819656/59f0deaa6e70/circrep-2-433-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b03/7819656/a4ff324efd28/circrep-2-433-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b03/7819656/546cb76ef595/circrep-2-433-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b03/7819656/59f0deaa6e70/circrep-2-433-g003.jpg

相似文献

1
Sudden Cardiac Death-Relevant Events of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From the Kochi RYOMA Study.日本某地区队列中肥厚型心肌病的心脏性猝死相关事件——高知县龙马研究结果
Circ Rep. 2020 Jul 2;2(8):433-439. doi: 10.1253/circrep.CR-20-0056.
2
Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者新发心房颤动的临床意义。
ESC Heart Fail. 2021 Dec;8(6):5022-5030. doi: 10.1002/ehf2.13563. Epub 2021 Sep 2.
3
Patients' Characteristics and Clinical Course of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From Kochi RYOMA Study.日本地区队列研究-高知县 Ryoma 研究:肥厚型心肌病患者的特征和临床过程。
Circ J. 2018 Feb 23;82(3):824-830. doi: 10.1253/circj.CJ-17-0845. Epub 2018 Jan 13.
4
Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.比较肥厚型心肌病和除颤器患者新的风险预测模型(HCM Risk-SCD)和经典风险因素对猝死的预测价值。
Europace. 2016 May;18(5):773-7. doi: 10.1093/europace/euv079. Epub 2015 Apr 7.
5
Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.安大略省年轻人肥厚型心肌病相关心源性猝死。
Circulation. 2019 Nov 19;140(21):1706-1716. doi: 10.1161/CIRCULATIONAHA.119.040271. Epub 2019 Oct 21.
6
Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者心脏磁共振成像显示的弥漫性心室纤维化与室性心动过速相关。
J Cardiovasc Electrophysiol. 2016 May;27(5):571-80. doi: 10.1111/jce.12948. Epub 2016 Mar 14.
7
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.肥厚型心肌病中的非持续性室性心动过速:年轻患者猝死风险的独立标志物。
J Am Coll Cardiol. 2003 Sep 3;42(5):873-9. doi: 10.1016/s0735-1097(03)00827-1.
8
Prolonged mHealth-Based Arrhythmia Monitoring in Patients With Hypertrophic Cardiomyopathy (HCM-PATCH): Protocol for a Single-Center Cohort Study.肥厚型心肌病患者基于移动健康的心律失常长期监测(HCM-PATCH):单中心队列研究方案
JMIR Res Protoc. 2023 Dec 29;12:e52035. doi: 10.2196/52035.
9
Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.儿童 RAS 相关肥厚型心肌病中的心源性猝死:HCM 风险儿童模型的验证和事件预测因子。
Int J Cardiol. 2023 Dec 15;393:131405. doi: 10.1016/j.ijcard.2023.131405. Epub 2023 Sep 28.
10
Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.泰国成年肥厚型心肌病患者的死亡模式和临床结局。
BMC Cardiovasc Disord. 2019 Jan 3;19(1):1. doi: 10.1186/s12872-018-0984-0.

引用本文的文献

1
Incidence and Healthcare Resource Utilization Among Patients with Hypertrophic Cardiomyopathy Hospitalized for Heart Failure in Japan.日本因心力衰竭住院的肥厚型心肌病患者的发病率及医疗资源利用情况
Cardiol Ther. 2025 Jul 19. doi: 10.1007/s40119-025-00427-3.

本文引用的文献

1
Validation of the 2014 European Society of Cardiology Sudden Cardiac Death Risk Prediction Model Among Various Phenotypes in Japanese Patients With Hypertrophic Cardiomyopathy.验证 2014 年欧洲心脏病学会在日本肥厚型心肌病患者各种表型中的心脏性猝死风险预测模型。
Am J Cardiol. 2018 Dec 1;122(11):1939-1946. doi: 10.1016/j.amjcard.2018.08.042. Epub 2018 Sep 8.
2
Clinical Course and Management of Hypertrophic Cardiomyopathy.肥厚型心肌病的临床病程与管理
N Engl J Med. 2018 Aug 16;379(7):655-668. doi: 10.1056/NEJMra1710575.
3
Patients' Characteristics and Clinical Course of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From Kochi RYOMA Study.
日本地区队列研究-高知县 Ryoma 研究:肥厚型心肌病患者的特征和临床过程。
Circ J. 2018 Feb 23;82(3):824-830. doi: 10.1253/circj.CJ-17-0845. Epub 2018 Jan 13.
4
Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病高危患者非持续性室性心动过速的预后意义
Circ Arrhythm Electrophysiol. 2017 Mar;10(3). doi: 10.1161/CIRCEP.116.004604.
5
Prognostic Significance of Non-Dilated Left Ventricular Size and Mitral Regurgitation in Patients With Dilated Phase of Hypertrophic Cardiomyopathy.肥厚型心肌病扩张期患者非扩张性左心室大小及二尖瓣反流的预后意义
Int Heart J. 2017 Feb 7;58(1):63-68. doi: 10.1536/ihj.16-109. Epub 2017 Jan 11.
6
Guidelines for Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy (JCS 2012) - Digest Version .肥厚型心肌病患者的诊断与治疗指南(2012年日本循环学会版)——摘要版
Circ J. 2016;80(3):753-74. doi: 10.1253/circj.CJ-66-0122. Epub 2016 Feb 3.
7
MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside.磁共振成像在肥厚型心肌病中的应用:从磁场到床边。
Radiology. 2014 Nov;273(2):329-48. doi: 10.1148/radiol.14131626.
8
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).2014年欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗指南:欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗工作组
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
9
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.定量对比增强心血管磁共振对肥厚型心肌病患者猝死风险评估的预后价值。
Circulation. 2014 Aug 5;130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094.
10
Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan.肥厚型心肌病扩张期的临床特征和结局:来自日本登记数据的报告。
J Cardiol. 2013 Jan;61(1):65-70. doi: 10.1016/j.jjcc.2012.08.010. Epub 2012 Oct 15.